21 May 2013
Keywords: shreya, biotech, make, recombinant, human, insulin, end-2005
Article | 22 November 2004
Shreya Biotech of India plans to make recombinant human insulin from end-2005, to share in the growing 25,000kg-a-year global market.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2004
© 2013 thepharmaletter.com